Germany, WHO announce creation of new data hub to fight pandemics
05 May 2021 - 16:54
German Health Minister Jens Spahn arrives for the weekly cabinet meeting at the chancellery in Berlin, Germany May 5, 2021. John MacDougall/Pool via REUTERS
Reuters
GENEVA/BERLIN: German Health Minister Jens Spahn called on Wednesday for a global reset in the fight against pandemics as Germany and the World Health Organization (WHO) announced the creation of a new global hub in Berlin for gathering data on pandemics.
Speaking at a virtual news conference attended also by German Chancellor Angela Merkel and the head of the WHO, Spahn said the world was still insufficiently prepared for pandemics.
Wednesday, 05 May 2021 08:03 PM MYT
German Health Minister Spahn,said the world was still insufficiently prepared for pandemics. Reuters pic
Subscribe to our Telegram channel for the latest updates on news you need to know.
GENEVA/BERLIN, May 5 German Health Minister Jens Spahn called today for a “global reset” in the fight against pandemics as Germany and the World Health Organisation (WHO) announced the creation of a new global hub in Berlin for gathering data on pandemics.
Spahn, speaking at a virtual news conference attended also by German Chancellor Angela Merkel and the head of the WHO, said the world was still insufficiently prepared for pandemics.
Follow RT on Covid vaccine partners Pfizer and BioNTech have announced they’ve submitted a request for their inoculation, Comirnaty, to be given permission for its administration in those aged 12-15 following positive trial results.
In a statement on Friday, the two companies said they had applied for their conditional market authorization to be expanded in the EU, allowing adolescents to receive the jab. The pair had already submitted a similar request to the US Food and Drug Administration earlier in April.
The firms said that their vaccine had been tested on 2,260 participants aged 12 to 15 years and was
“generally well tolerated”.
âââ 07:54 Fri, 30 Apr 2021
BioNTech said Thursday that it expected its Covid-19 vaccine, jointly developed with Pfizer, to be available to 12- to 15-year-olds in Europe from June.
The German firm s CEO Ugur Sahin told Der Spiegel weekly that it was in the final stretches of preparing its submission for European regulatory approval.
The evaluation of the trial data takes four to six weeks on average , he added.
Vaccinating children is seen as a crucial next step toward herd immunity and ending the pandemic.
The prospect of getting older children inoculated before the next school year starts would also relieve the strain on parents who are juggling the demands of homeschooling while keeping up with jobs.
EU might have COVID-19 vaccine for teens by June: BioNTech
BioNTech-Pfizer earlier applied for US vaccine authorisation for young teens SAMAA | Health - Posted: Apr 29, 2021 | Last Updated: 4 hours ago SAMAA | Health Posted: Apr 29, 2021 | Last Updated: 4 hours ago
A teenager receives a shot in a clinical trial of Pfizer’s COVID-19 vacine. Photo: Cincinnati Children s Hospital
Listen to the story
BioNTech said Thursday that it expected its Covid-19 vaccine, jointly developed with Pfizer, to be available to 12 to 15-year-olds in Europe from June.
The German firm s CEO Ugur Sahin told Der Spiegel weekly that it was in the final stretches of preparing its submission for European regulatory approval.